reSee.it - Related Video Feed

Nine studies have found false positive HIV tests after COVID-19 infection and vaccination. Although it is not AIDS, there may be a form of immunodeficiency present. Dr. Ryan Cole presented data showing that the more COVID vaccines were taken, the higher the risk of recurrent COVID and other severe syndromes. Additionally, there have been cases of reactivation of varicella zoster, Epstein Barr, cytomegalovirus, and false positive HIV tests. An Australian investigation led by Melissa McCann on vaccine-acquired immune deficiency syndrome (VAIDS) is expected to provide valuable insights. It is believed that both COVID-19 infection and the vaccine can worsen immunity, leading to immunodeficiency.

They classified the post-vaccine troubles into three categories: immediate effects like pain, swelling, and redness; symptoms resembling COVID-19; and post-COVID injection syndromes. The latter includes inflammatory and multisystemic syndromes with various complications such as cardiac, neurological, hematological, vascular, immune system, reproductive health, cancer, and congenital issues. It is important to consult a doctor if experiencing any of these symptoms.

Yale experts have identified post-vaccination syndrome (PVS) linked to mRNA COVID vaccines, causing brain fog, dizziness, tinnitus, and exercise intolerance. Sufferers show immune cell changes and coronavirus proteins even without having had COVID. The condition may reactivate the Epstein Barr virus. PVS patients had higher COVID spike protein levels than long COVID patients. This may be due to the shots' genetic material integrating with human genes, constantly activating protein production, raising safety concerns. Some believe the censorship of early vaccine side effect stories was brutal. There's a correlation between vaccine rates and unexplained deaths, but more research is needed to fully understand these mechanisms. To keep Infowars going, check out survival shield x2, brain force ultra, body's ultimate formula, vitamin C with zinc, vaso beets, ultra twelve, pain MD, The Great Awakening book, and Infowars gold collectible art card at infowarsstore.com.

VAERS, the Vaccine Adverse Event Reporting System, collects data on vaccine-related adverse events. Analysis shows that in 2021, 98% of cancer-related reports were linked to COVID vaccines, significantly higher than other vaccines. A comparison with the flu vaccine revealed virtually no cancer cases associated with it, highlighting a stark contrast. Research indicates that PD L1, a receptor produced by cancer and immune cells, may contribute to this issue. Elevated PD L1 levels were observed two days after vaccination, suggesting an activated immune system may suppress responses to both COVID and cancer. This nonspecific immunosuppressive effect raises concerns about the potential for increased cancer risk following vaccination.

The discussion centers on evidence linking myocarditis and pericarditis to mRNA vaccination and the proposed mechanism behind it. It references a 2022 German study reporting that endomyocardial biopsy data from people with myocarditis showed cardiac detection of the spike protein and CD4+ T cell–dominated inflammation, suggesting a vaccine-triggered autoimmune reaction. The presenters note headlines at the time comparing myocarditis risk to infection, with claims that infection causes more myocarditis, and remind that vaccines were said not to stop transmission. They then cite a large Israeli population study from the same year involving subjects not vaccinated against SARS-CoV-2, which found no increase in the incidence of myocarditis or pericarditis, implying no observed vaccine-related signal in that cohort. Attention shifts to a more recent study published in Circulation by the American Heart Association, described as a high-impact, non-fringe journal, indicating a clearer mechanism has been demonstrated. The study described used an experimental mouse model to induce cardiac damage and then compared it to human cases with heart damage following vaccination. It states that T cells from patients with acute myocarditis or myopericarditis recognize vaccine-encoded spike epitopes that are homologous to cardiac self proteins, meaning the immune response to the spike protein can cross-react with heart tissues. The researchers further report that functional responses to potassium channels in patients with mild pericarditis after mRNA vaccination, but not in patients with COVID-19, showed an expanded pattern of cytokine production similar to that observed in myopericarditis mice and in autoimmune myocarditis. In plain terms, the summary of their takeaway is that post-mRNA vaccine myopericarditis is driven by molecular mimicry: the immune system cannot distinguish self from non-self, leading to an autoimmune attack on heart tissue in susceptible patients. The distribution of the vaccine (its widespread dissemination) is cited as a factor that makes patients susceptible by promoting heart-homing imprinting, effectively creating an anti-heart autoimmune response. The speakers emphasize that this Circulation article is a top-tier source, underscoring that the mechanism has been demonstrated with both animal models and human pathology, supporting the claim that the phenomenon has a defined immunological basis.

Nine studies have reported false positive HIV tests after COVID-19 infection or vaccination, suggesting a potential immunodeficiency. Dr. Ryan Cole presented data showing that the more COVID vaccines were taken, the higher the risk of recurrent COVID. There have also been cases of severe syndromes and reactivation of viruses like varicella zoster, Epstein Barr, and cytomegalovirus. An Australian investigation into vaccine-acquired immune deficiency syndrome (VAIDS) led by So McCann is expected to provide important insights. It is believed that both COVID-19 and the vaccines may worsen immunity, with some people experiencing immunodeficiency.

The symposium covers the potential safety and threat of “replicating” vaccines, especially LepriCon (leprecon) vaccines, in the context of Covid-19 vaccines and genome‑editing concepts. The speakers present a chain of claims and concerns, some drawing on reports and others presenting theories about how these next‑generation vaccines could behave in humans and populations. Key points and claims presented - Emerging mechanisms and risks: The panel notes that blood vessel inflammation and thrombosis mechanisms are increasingly observed, including in vaccine contexts, with examples from individuals who needed limb amputation and others who developed severe vascular events after vaccination. One case involved a 70‑year‑old man who, after a third dose, developed embolic events necessitating shoulder joint surgery, and another where a 60‑year‑old man developed acute limb ischemia and died; both are presented as suggesting a serious vascular mechanism linked to vaccination, though causal connections are not established. - Replicating/vector vaccines and their concerns:荒川博士 and others discuss LepiCon vaccines as vaccines that replicate inside the body. The concept involves “replicating viral vectors” where the genome can mutate and evolve during replication. The green‑highlighted segment in a slide (the antigen gene) plus a blue/orange segment (replicating gene cassette) is used to describe how LepriCon vaccines are designed to carry viral genes and replicate, with the assertion that replication, mutation, and recombination can occur, potentially generating new variants inside the host. - Differences from conventional vaccines: The discussion contrasts LepriCon vaccines with standard mRNA vaccines. In conventional mRNA vaccines, messenger RNA is delivered and translated into antigen proteins, then degraded; in LepriCon vaccines, replicating RNA/DNA can persist and continue producing antigen, with mutation and recombination possible. The panel emphasizes that LepriCon vaccines use replicating/copying mechanisms and that the genetic material can be copied in ways that differ from natural human biology, potentially creating unpredictable variants. - Central dogma and exceptions: The speakers reference the central dogma (DNA → RNA → protein) but note exceptions in viruses, including RNA viruses that can reverse‑transcribe to DNA (retroviruses) and RNA viruses that replicate RNA directly. They discuss how LepriCon vaccines would rely on replicative processes that do not follow the usual linear flow and why this could complicate predictions about safety and behavior in humans. - Potential for unintended spread and environmental impact: A major concern raised is that self‑replicating vectors could spread beyond the vaccinated individual, via exosomes or other intercellular transport, creating secondary infections or non‑target spread. Exosomes could ferry replicating genetic material, raising fears of new infection chains or “outbreaks” stemming from the vaccine itself, and even suggesting the possibility of vaccination‑induced spread akin to an attenuated or modified pathogen. - Safety signals and immunology concerns: The discussion touches on immune system risks, including immune dysregulation, autoimmune phenomena, and unexpected inflammatory responses. IGG4‑related disease is highlighted as a potential adverse outcome post‑vaccination, with descriptions of glandular and systemic involvement and the idea that high IGG4 levels could have immunosuppressive effects that alter responses to infection or vaccination. The panel notes observed increases in certain immunoglobulin subclasses after multiple LepriCon doses and discusses the possibility of immune tolerance or enhanced immune responses that could be harmful. - Historical and theoretical context: References are made to past epidemics and speculative pandemics caused by misused or dangerous vaccine platforms, drawing on central molecular biology concepts and historical anecdotes about how vaccines can be designed and misused. The discussion frames LepriCon vaccines as a high‑risk platform that could, in theory, generate recombinants, escape mutations, or cause unintended immune and inflammatory consequences. - Clinical and regulatory implications: The speakers call for caution, arguing that more evidence is needed before approving or widespread use of LepriCon vaccines. They emphasize the need for long‑term observation and transparent communication about risks, and criticize the potential for insufficient understanding among healthcare workers and the public. They also urge that any future vaccine development should consider the possibility of genome editing, recombination, and exosome‑mediated spread, and stress the importance of not underestimating possible adverse effects. - Real‑world observations and skepticism about hype: Several speakers underscore that the danger is not merely hypothetical; there are reports of adverse events, including stroke‑like conditions, inflammatory diseases, and immune dysregulation in vaccinated individuals. They stress that the evolution and mutation of replicating vaccines could outpace current surveillance methods, and that “information manipulation” or lack of transparent reporting could mislead the public about risks. - Final reflections and call to action: The concluding messages advocate recognizing the potential failures of messenger RNA vaccines and acknowledging that both conventional and replicating platforms may carry risks. The speakers urge ongoing critical analysis, cautious progression, and robust verification of claims through transparent, independent investigation. They close with thanks to the organizers and a hope that the discussion may contribute to broader public awareness and informed decision‑making. Notable emphasis and unique considerations - The core concern centers on LepriCon vaccines’ replication, mutation, and potential to spread beyond the vaccinated person; exosome transport and genomic/cellular integration are highlighted as mechanisms that could generate new risks not present with non‑replicating vaccines. - The discussion stresses that IGG4 responses could become alarmingly high after certain doses, potentially leading to immunosuppressive effects or autoimmune phenomena, and presents IGG4‑related disease as a potential complication to monitor. - The speakers insist that safety and transparency are paramount, and that misinformation or optimistic narratives about rapid vaccine development could lead to harm if new platforms are adopted without comprehensive evaluation. Overall, the symposium foregrounds cautious scrutiny of replicating vaccine platforms, frames potential biological and regulatory risks, and calls for careful, evidence‑based assessment before broader deployment.

The speaker describes a nationwide study conducted in South Korea, stating that every resident was included in the research. The study compared individuals who received the vaccine to those who did not, and the analysis was stratified by dose number (one dose, two doses, three doses, and four or more doses). A central claim of the speaker is that this study provides the strongest signal to date supporting vaccine acquired immunodeficiency syndrome, referred to as VADES. According to the speaker, as each dose was administered, the immune function of individuals declined. By the time of the fourth dose, the speaker asserts there was a significant increase in the risk of other infections, quantified as about a 550% increase, including infections such as the common cold, tuberculosis, and upper respiratory tract infections. The speaker notes that the effect was most pronounced in young people, specifically ages zero to nineteen, who reportedly had the highest risks of these other infections. The implication presented is that the injections are causing immune collapse and exhausting T cells, leading to immune dysregulation described as IgG4 class switching. The immune system is said to become dysfunctional as a result. Additionally, the speaker mentions that, consistent with other studies they reference, genes related to immune function are claimed to become shut down. The overall assertion is that these findings point to a troubling pattern of immune impairment associated with multiple vaccine doses, culminating in the claimed immune dysfunction and increased susceptibility to other infections. The speaker emphasizes the magnitude and reliability of the sample size, stating that having an entire country’s population as the study cohort constitutes the strongest possible sample size. The summary of the presented claims centers on dose-dependent immune decline, a marked increase in non-target infections after the fourth dose, greater impact on children, evidence of immune system exhaustion and dysregulation, and purported genetic downregulation of immune pathways, all described as arising from the vaccination regimen in this nationwide South Korean study.

A new study published in Frontiers in Medicine reveals that COVID-19 vaccination may double the risk of post-COVID death after one year. The research analyzed over 15,000 severe acute respiratory syndrome cases in Brazil from 2020 to 2023, finding that while vaccination initially reduced mortality risk, this effect reversed long-term. The study recorded 5,157 deaths, with higher risks among older adults and those with less education. The authors suggest that the initial protective effect could be linked to healthier behaviors among vaccinated individuals, while long-term risks may arise from vaccine-related adverse effects. The findings call for further investigation into these trends, emphasizing the need for reevaluation of vaccination policies. The discussion also highlights the broader implications for public health and the urgent need for accountability regarding vaccine safety.

A study comparing gene profiles of 800 healthy individuals to mRNA-injured individuals found severe genetic dysregulation in the latter. Seven of the injured individuals developed new-onset cancers within a year of mRNA injection, while three experienced cardiovascular or long vaccine syndrome. Gene expression comparisons revealed thousands of dysregulated gene expressions in the mRNA-injured, linked to mitochondrial failure and oncogenic activations. Cancer suppression genes were not being suppressed, and immune dysregulation was observed. The study claims to be the first to show long-term genetic disruptions in the vaccinated, indicating molecular chaos within cells. This may be the biological mechanism behind cardiovascular and carcinogenic issues seen in the vaccinated, possibly due to genomic integration of DNA plasmids from the manufacturing process. The speaker states that this is a landmark report and calls for further investigation into the effects on the population, noting that a large percentage of the global population received COVID vaccines.

Vaccinated individuals are experiencing concerning symptoms like fatigue, mood swings, and weakened immune responses. A Yale study has revealed evidence of Vaccine Induced Autoimmune Deficiency Syndrome (VAIDS), showing a drop in immune cells and the presence of spike proteins long after vaccination. This has sparked internal conflict at Yale regarding the publication of these findings, which could expose vaccine risks. Additionally, there are rising cases of aggressive cancers and positive HIV tests among vaccinated individuals, attributed to vaccine-induced immunodeficiency. Despite this alarming data, mainstream media continues to downplay the issues, raising questions about accountability and transparency surrounding vaccine safety. The urgency to spread awareness about these findings is critical as the implications for public health are significant.

The authors discuss the unusual presence of IgG4 antibodies in mRNA vaccinated individuals, which is not typically seen post-virus infection. IgG4 antibodies are usually associated with parasite infections, allergens, autoimmune diseases, and cancer. The immune system's recognition of repeated antigens can induce IgG4 production, potentially leading to t cell exhaustion and autoimmunity. Scientists are cautious about the implications of IgG4 antibodies and suggest further research comparing outcomes among vaccinated and unvaccinated individuals. This data analysis may reveal any potential clinical impacts over time.

The speaker observed vasculitis, or inflammation of the blood vessels, in the brain tissue of almost all cases examined post-vaccination. Lymphocytes aggregate around small vessels, indicating inflammation possibly triggered by an antigenic structure like spike protein. This was described as one of the most alarming findings. Individuals with this complication may experience transient defects like loss of speech, unconsciousness, or blindness, but the brain can compensate if there is no major inflammation or hemorrhage. The speaker clarified that the individuals did not die from the vasculitis itself. It's possible for vaccinated individuals to experience these symptoms without knowing the underlying cause. Changes in character have been reported in some vaccinated individuals, which may be related to this inflammation.

Some individuals are experiencing health issues that resemble long COVID, but are actually due to mRNA vaccines. These can include cognitive dysfunction, such as severe word recall problems, and a condition where patients feel suffocated despite normal heart and lung function. This is linked to issues with blood returning to the heart. Autonomic dysfunction is also noted, with some patients unable to sit up without severe symptoms. While these conditions can be serious, they are often reversible over time, potentially driven by residual spike protein from the vaccines. The mRNA vaccines turn the body into a spike protein factory, which raises concerns about their safety. An alternative, the Novavax protein vaccine, provides a controlled amount of spike protein without these risks and should be considered more critically.

The mRNA COVID-19 vaccine delivers instructions for creating spike proteins, which then trigger an immune response. The vaccine components are said to break down and disappear from the body within days, leaving no trace and unable to affect DNA. However, some claim that data from the Therapeutic Goods Administration in Australia shows the vaccine distributes throughout the body, not just the injection site, and that there was no data on how quickly it degrades. Research indicates vaccine mRNA can be detected in some individuals for up to 14-15 days. A rare post-vaccination syndrome (PVS) is described where individuals exhibit elevated levels of spike protein for extended periods, up to 709 days, along with reactivation of dormant viruses. A hypothesis suggests that in some individuals, the vaccine mRNA may reverse transcribe and integrate into DNA, causing continuous spike protein production and potentially leading to T-cell exhaustion. The concern is raised about the long-term health consequences and potential for germline transfer if DNA is altered.

Speaker 0 describes what he claims is the strongest case report ever done on vaccine injury, specifically mRNA vaccine injury. The subject is a 51-year-old man who developed myocarditis, pulmonary embolism, neurological disturbances, and skin disturbances, constituting multisystem long vaccine syndrome. The key findings are said to be detected 3.6 years after his last shot. Exosomes circulating in his body allegedly contain Pfizer mRNA, and this mRNA is still present in those exosomes years after vaccination. The same mRNA is reportedly also found in his skin. In addition, plasmid DNA from the manufacturing process is claimed to be present in his skin, again 3.6 years after vaccination. Specifically, the plasmid DNA allegedly includes the SV40 segment, the spike expression cassette, and the open reading frame region, with all components of the plasmids in the Grover's disease–affected skin area. Microscopic analysis of the Grover’s disease area allegedly showed staining for SARS-CoV-2 spike or vaccine spike, indicating the presence of spike protein in that skin region. This staining for spike protein is reported as occurring 3.6 years after the shot. Overall, the speaker asserts that all vaccine components—mRNA, plasmid DNA with defined segments, and spike protein—remain in the body for multiple years, with findings in exosomes and skin indicating long-lasting presence. The speaker also asserts that this represents a situation in which “we were completely lied to.”

They classified the post-vaccine troubles into three categories: immediate effects like pain, swelling, and redness; symptoms resembling COVID-19; and post-COVID injection syndromes. The latter includes inflammatory and multisystemic syndromes with various complications such as cardiac, neurological, hematological, vascular, immune system, reproductive health, cancer, and congenital issues. It is important to consult a doctor if experiencing any of these symptoms.

Residual effects from one or two COVID shots can include late blood clots and cardiac arrests years later. The mRNA and spike protein from the shots can linger in the body, causing various health issues like heart and brain damage, blood clots, and immunologic problems. A spike detox program is recommended to address these concerns.

A new Yale Medical School study reveals that individuals experiencing long COVID may actually be suffering from mRNA vaccine injuries, specifically vaccine-induced AIDS (VAIDs). The study, led by Bornalli Botticelli, indicates that mRNA injections alter human biology, leading to long-term spike protein production that increases over time. Scientists warn that these vaccines change T-cell immunophenotypes, triggering VAIDs. We were forced to take these experimental vaccines or risk losing our jobs, and we were lied to about their safety and efficacy. The vaccines didn't prevent contraction or transmission of the virus, and they caused heart issues, blood clots, and autoimmune disorders. Now, we're finding out that the mRNA jab causes VAIDs in many people, marking one of the most egregious scandals in American history.

Yale researchers discovered COVID spike proteins in the blood of individuals who received mRNA vaccines, even up to two years post-vaccination, without prior COVID infection. This raises concerns that the vaccine's genetic material may have integrated with human DNA, leading to ongoing spike protein production. While the findings suggest potential long-term effects, they do not definitively prove genetic integration. The researchers plan to publish their findings on a preprint server and seek validation from an independent lab. These developments could have significant implications for mRNA vaccine safety guidelines affecting over a billion vaccinated individuals. Further details will be shared as the research progresses.

The mRNA COVID-19 vaccine delivers instructions for creating spike proteins, which then triggers an immune response. The vaccine and spike protein are said to break down and disappear within days, leaving no trace and not affecting DNA. The vaccine is taken up at the injection site and quickly metabolized. However, an Australian Therapeutic Goods Administration document indicates the vaccine distributes throughout the body, including adipose tissue, adrenal glands, and the brain. There was allegedly no data on how quickly the mRNA degrades. Research indicates vaccine mRNA can be detected up to 14-15 days post-vaccination in some individuals. A rare post-vaccination syndrome (PVS) is associated with chronic conditions and elevated spike protein levels up to 709 days post-vaccination, even without detectable SARS-CoV-2 infection. One hypothesis suggests that the mRNA may reverse transcribe and integrate into DNA, causing continuous spike protein production and potentially leading to T cell exhaustion. The possibility of germline transfer and long-term health consequences is raised.

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

They classified post-vaccine issues into three categories: immediate effects like pain, swelling, and redness, but vomiting, diarrhea, fainting, etc. are not considered immediate side effects. They also mentioned Covid-like illnesses that resemble Covid-19, with data from Israel showing that 11% of people had Covid within two weeks of the anti-Covid injection. They warned about post-Covid injection syndrome (P0IS or P0V), which includes various inflammatory, multisystemic problems like cardiac, neurological, hematological, vascular, immune system, reproductive health, cancer, and congenital complications. This classification highlights the wide range of adverse effects and raises concerns about the vaccine's safety.

The symptoms of long COVID, such as joint pain, difficulty concentrating, brain fog, and chronic fatigue, can significantly affect patients' lives. The severity and occurrence of these symptoms vary among individuals and are not necessarily related to age, gender, or the severity of the initial COVID infection. Factors like the type of vaccine, individual constitution, age, and gender may contribute to the development of long COVID. Vaccinated individuals may experience a greater impact from long COVID compared to those who are unvaccinated. It is important to distinguish long COVID from other conditions, and while the vaccine may play a role, it is not clear if it can trigger long COVID.

A Yale Medical School study has allegedly found that people suffering from long COVID are actually suffering from mRNA vaccine injury, specifically vaccine-induced AIDS (VAIDS). According to Slay News, Yale University scientists have confirmed that COVID mRNA vaccines cause VAIDS. The study, led by Bornalli Bhattachary, reportedly found that mRNA injections alter human biology, creating long-term spike protein production that increases over time. The scientists warned that the COVID mRNA vaccines alter t-cell immunophenotypes, which triggers VAIDS. The speaker claims people were forced to take an experimental vaccine, lied to about its efficacy and safety, and censored for questioning it. The speaker asserts the mRNA jab causes VAIDS in many people and calls it one of the most egregious scandals in American history. The speaker suggests that everyone involved should be imprisoned.